Literature DB >> 1694307

Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.

M Matsuda1, B J Mayer, Y Fukui, H Hanafusa.   

Abstract

Although the oncogene product of CT10 virus, P47gag-crk, does not itself phosphorylate proteins at tyrosine residues, it elevates phosphotyrosine in transformed cells. The P47gag-crk oncoprotein contains SH2 and SH3 domains, which are conserved in several proteins involved in signal transduction, including nonreceptor tyrosine kinases. P47gag-crk bound in vitro to phosphotyrosine-containing proteins from crk-transformed cells and from cells transformed by oncogenic tyrosine kinases. The association between P47gag-crk and p60v-src, a phosphotyrosine-containing protein, was abolished by dephosphorylation of p60v-src. This suggests that the SH2 and SH3 regions function to regulate protein interactions in a phosphotyrosine-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694307     DOI: 10.1126/science.1694307

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  122 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 2.  Protein-protein interactions in signaling cascades.

Authors:  B J Mayer
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

3.  Cytokine regulation of gap junction connectivity: an open-and-shut case or changing partners at the Nexus?

Authors:  C F Brosnan; E Scemes; D C Spray
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

4.  CMS: an adapter molecule involved in cytoskeletal rearrangements.

Authors:  K H Kirsch; M M Georgescu; S Ishimaru; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.

Authors:  Keith Q Tanis; Darren Veach; Henry S Duewel; William G Bornmann; Anthony J Koleske
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

6.  Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences.

Authors:  R J Matthews; D B Bowne; E Flores; M L Thomas
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

7.  Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

Authors:  M Matsuda; C T Reichman; H Hanafusa
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.

Authors:  R B Birge; J E Fajardo; C Reichman; S E Shoelson; Z Songyang; L C Cantley; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.